Literature DB >> 6298470

Alterations in the structure of the oligosaccharide of vesicular stomatitis virus G protein by swainsonine.

M S Kang, A D Elbein.   

Abstract

Swainsonine, an inhibitor of glycoprotein processing, inhibits the formation of the normal oligosaccharide chain of the G protein of vesicular stomatitis virus. Thus, when vesicular stomatitis virus was grown in baby hamster kidney cells in the presence of swainsonine (15 to 500 ng/ml) and labeled with [2-(3)H]mannose, the oligosaccharide portion of the G protein was completely susceptible to the action of endoglucosaminidase H. However, the normal viral glycoprotein is not susceptible to this enzyme. Various enzymatic treatments and methylation studies of the mannose-labeled oligosaccharides suggest that swainsonine causes the formation of a hybrid-type oligosaccharide having an oligomannosyl core (Man(5)GlcNAc(2)-Asn) characteristic of neutral oligosaccharides plus the branch structure (NeuNAc-Gal-GlcNAc) characteristic of the complex oligosaccharides. A structure for this hybrid oligosaccharide is proposed. Swainsonine had no effect on the incorporation of [(14)C]leucine into viral proteins, nor did it change the number of PFU produced in these cultures. It did, however, slightly decrease the incorporation of [(3)H]glucosamine and increase the incorporation of [(3)H]mannose. Vesicular stomatitis virus raised in the presence of swainsonine bound much more tightly to columns of concanavalin A-Sepharose than did control virus. Swainsonine had to be added within the first 4 or 5 h of virus infection to be effective. Thus, when 100 ng of the alkaloid per ml was added at any time within the first 3 h of infection, essentially all of the glycoprotein was susceptible to digestion by endoglucosaminidase H. However, when swainsonine was added 4 h after the start of infection, 30% of the glycopeptides became resistant to endoglucosaminidase H; at 5 h, 70% were resistant. The effect of swainsonine was reversible since removal of the alkaloid allowed the cells to form the normal complex glycoproteins. However, the time of removal was critical in terms of oligosaccharide structure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298470      PMCID: PMC255093     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Partial structural analysis of the oligosaccharide moieties of the vesicular stomatitis virus glycoprotein by sequential chemical and enzymatic degradation.

Authors:  J R Etchison; J S Robertson; D F Summers
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

2.  Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus.

Authors:  L A Hunt; J R Etchison; D F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  Proposal for a common oligosaccharide intermediate in the synthesis of membrane glycoproteins.

Authors:  P W Robbins; S C Hubbard; S J Turco; D F Wirth
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

4.  Localization of the enzyme system for glycosylation of proteins via the lipid-linked pathway in rough endoplasmic reticulum.

Authors:  U Czichi; W J Lennarz
Journal:  J Biol Chem       Date:  1977-11-25       Impact factor: 5.157

5.  Control of glycoprotein synthesis. Lectin-resistant mutant containing only one of two distinct N-acetylglucosaminyltransferase activities present in wild type Chinese hamster ovary cells.

Authors:  S Narasimhan; P Stanley; H Schachter
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

Review 6.  Comparative aspects of glycoprotein structure.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

7.  Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.

Authors:  A L Tarentino; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

8.  The structure of the Aerobacter aerogenes A3(S1) polysaccharide. I. A reexamination using improved procedures for methylation analysis.

Authors:  P A Sandford; H E Conrad
Journal:  Biochemistry       Date:  1966-05       Impact factor: 3.162

9.  Studies on the attachment of carbohydrate to ovalbumin nascent chains in hen oviduct.

Authors:  M L Kiely; G S McKnight; R T Schimke
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

10.  Lysosomal alpha-D-mannosidase of rat liver. Purification and comparison with the golgi and cytosolic alpha-D-mannosidases.

Authors:  D J Opheim; O Touster
Journal:  J Biol Chem       Date:  1978-02-25       Impact factor: 5.157

View more
  13 in total

1.  Properties of baby-hamster kidney (BHK) cells treated with Swainsonine, an inhibitor of glycoprotein processing. Comparison with ricin-resistant BHK-cell mutants.

Authors:  L Foddy; J Feeney; R C Hughes
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

2.  Castanospermine inhibits glucosidase I and glycoprotein secretion in human hepatoma cells.

Authors:  V W Sasak; J M Ordovas; A D Elbein; R W Berninger
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

3.  Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression.

Authors:  E J Nichols; R Manger; S Hakomori; A Herscovics; L R Rohrschneider
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

4.  Swainsonine-induced oligosaccharide excretion in sheep. Time-dependent changes in the oligosaccharide profile.

Authors:  P F Daniel; C D Warren; L F James
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

5.  Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2.

Authors:  K A Wall; J D Pierce; A D Elbein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  The effects of processing inhibitors of N-linked oligosaccharides on the intracellular migration of glycoprotein E2 of mouse hepatitis virus and the maturation of coronavirus particles.

Authors:  R Repp; T Tamura; C B Boschek; H Wege; R T Schwarz; H Niemann
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

7.  Hazelhurst-vesicular-stomatitis-virus G and Sindbis-virus E1 glycoproteins undergo similar host-cell-dependent variation in oligosaccharide processing.

Authors:  S K Davidson; L A Hunt
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

8.  Accessibility to proteases of the cytoplasmic G protein domain of vesicular stomatitis virus is increased during intracellular transport.

Authors:  D Mack; B Kluxen; J Kruppa
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

9.  Effects of inhibitors of glycoprotein processing on the synthesis and biological activity of the erb B oncogene.

Authors:  J A Schmidt; H Beug; M J Hayman
Journal:  EMBO J       Date:  1985-01       Impact factor: 11.598

10.  Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex.

Authors:  H F Lodish; N Kong
Journal:  J Cell Biol       Date:  1984-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.